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Abstract
We present the case of a 46 year old woman with a giant, 23-centimeter, atypical carcinoid of the
liver. A primary site for this neoplasm could not be identified despite multiple radiographic imaging
studies, including a somatostatin scan, and a thorough inspection of the bowel during surgical
resection of the lesion. Histologically, the tumor displayed mild cytologic atypia, abundant necrosis,
and intravascular metastases, the last feature of which was identified by immunohistochemical
markers for chromogranin and synaptophysin. Also described is the unusual sinusoidal infiltration,
or "spillage," of tumor cells into the surrounding liver parenchyma, a feature that has not been
described as far as we are aware but may suggest an aggressive clinical course. Even though an exact
definition of atypia for these lesions apparently does not exist at this point, the multiple atypical
features in this case strongly suggest the diagnosis of atypical carcinoid of the liver, thus far an
altogether rare and vaguely reported entity. As more cases arise in the medical literature, it may
be worthwhile to establish a set of guidelines to define atypical hepatic carcinoids and other
gastrointestinal carcinoids, although survivorship data thus far indicates no significant difference in
the prognosis between typical versus atypical variants.
Background
Primary hepatic carcinoid tumor is an incredibly rare
entity but must be distinguished from other lesions such
as hepatocellular carcinoma because of its different treat-
ment and prognostic implications. At this time about 125
cases have been reported, but many of these may have
been metastases or a neuroendocrine component of
another neoplasm [2]. Even rarer is the entity of primary
hepatic atypical carcinoid, with only 19 cases so far men-
tioned in the literature [1]. We present the case of a giant
atypical carcinoid tumor that, as far as we can determine,
is primary to the liver and displays the unusual his-
topathologic phenomenon of sinusoidal infiltration
throughout the surrounding liver parenchyma.
Case Presentation
The patient was a 46-year-old white female who presented
with vague right upper abdominal pain and fullness for
approximately one and a half months' duration. This pain
intensified in a seated position. Besides having a chronic
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wise felt healthy and had not visited a physician for the
past twenty years.
Physical examination revealed a large, firm mass within
the right upper quadrant that extended 10 cm below the
right costal margin and stretched horizontally from the
epigastric midline to the right lateral abdominal wall.
An axial CT scan demonstrated a heterogeneous enhance-
ment of a 22 × 14 cm hepatic mass involving the right
hepatic lobe with a central region of hypoattenuation
(Figure 1). Magnetic resonance imaging showed a 23 × 16
× 14 cm intraparenchymal hepatic mass virtually replac-
ing the right lobe of the liver while medially displacing the
portal vein and inferior vena cava. Ingrowth into these
vascular structures could not be identified. The right kid-
ney and right hemidiaphragm revealed caudal and cranial
displacement, respectively. No other lesions were identi-
fied.
An ultrasound-guided liver core biopsy procedure was
performed a week later. The pathology report issued the
diagnosis "neuroendocrine neoplasm" with a differential
diagnosis that included carcinoid tumor, gastrinoma,
insulinoma, and hepatocellular carcinoma with neuroen-
docrine features.
Subsequently, the patient underwent a somatostatin scan,
involving the administration of 6 millicuries of indium-
111 and use of a plantar gamma camera and single pho-
ton emission computed tomography (SPECT). The study
identified an abundance of heterogenous activity within
the hepatic mass but detected no extrahepatic foci of activ-
ity.
Based upon the pathologic and radiologic findings, the
surgical team decided to perform a right hepatic lobec-
tomy.
Materials and methods
5-um sections from formalin-fixed, paraffin-embedded
tissue were used for routine light microscopic study and
immunohistochemical analysis including the antibodies
specified in Table 1. These immunohistochemical stains
were performed with a labeled avidin-biotin complex
immunoperoxidase method using commercially available
monoclonal antibodies and DAB as the chromogen. In
order to provide negative controls on patient tissue and
thereby ensure specificity of the reactions, the aforemen-
tioned antibodies were substituted for an unrelated anti-
body during the incubation procedure. Formalin-fixed
and paraffin-embedded pancreatic tissue was used as a
positive control for synaptophysin, chromogranin, and
neuron-specific enolase (NSE); hepatic tissue for alpha-
fetoprotein (AFP) and Hep-Par1; and epidermis for cytok-
eratin.
Pathologic findings
The 4300-gram right lobe partial hepatectomy specimen
revealed a 23 × 17 × 14 cm dark brown-to-tan, multilobu-
lated mass with abundant areas of hemorrhage and necro-
sis that nearly replaced the entire normal liver tissue
(Figure 2A). A large, irregular area of scarring filled the
central portion of the neoplasm (Figure 2B). Multiple
areas overlying the anterior capsule were pale and indu-
rated, suspicious for capsular involvement by the lesion.
Table 1: Immunohistochemical stains used to establish the 
diagnosis of the neoplasm, including the vendors as well as the 
clones and dilutions used
Antibody Dilution Vendor Clone
Synaptophysin 1:100 Dakocytomation --
Chromogranin-A 1:100 Dakocytomation DAK-A3
NSE 1:100 Dakocytomation BBS/NC/VI-H14
Cytokeratin 1:400 Biocare Medical AE1/AE3+5D3
Hep-Par1 1:100 Dakocytomation OCH1E5
AFP Pre-dil Zymed Laboratories ZSA06
NSE: Neuron-specific enolase, AFP: alpha-fetoprotein, Pre-dil: pre-
diluted.
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An axial CT image obtained during hepatic arterial phase 
demonstrates a heterogeneous enhancement of an approxi-
mately 22 × 14 cm hepatic mass involving the right hepatic 
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specimen.
The lesion was composed of a monomorphic cell popula-
tion arranged in a predominately trabecular architecture
and with some scattered acinar arrangements (Figure 2C).
The borders of the lesion pushed into the surrounding
normal liver parenchyma. Cytologically, the cells showed
minimal atypia and possessed eccentric, speckled nuclei
with cytoplasmic granularity and eosinophilia (Figure 2C,
inset). Mitoses were rare while hemorrhage and necrosis
were diffusely present in varying degrees. Sections taken
from the central area of the tumor showed early scar for-
mation with scattered tumor islands. Capsular invasion
was not identified.
Immunohistochemical stains for chromogranin, synapto-
physin, and NSE showed a strong, diffuse positivity for the
tumor cells. Multiple intrahepatic, intravascular tumor
cell metastases were visualized with these markers as well,
especially with chromogranin (Figure 3A). Both the syn-
aptophysin and chromogranin markers highlighted
tumor cells scattered throughout the sinusoids of the sur-
rounding liver parenchyma (Figures 3B), suggesting local
invasion by individual cells and small cell clusters. None
of this sinusoidal "spillage" could be identified at the
parenchymal surgical resection margin.
The marker for cytokeratin revealed a cytoplasmic, granu-
lar staining pattern while markers for Hep-Par1, alpha-
fetoprotein (AFP), and mucicarmine did not highlight the
neoplastic cells.
Discussion
Approximately 125 cases of primary hepatic carcinoids
have been described within the literature. Atypical pri-
mary hepatic carcinoids appear to be much less common,
as the 19 cases reported by Soga in 2002 currently stand as
the only such designated entities. Females are affected
slightly more often than males (1.4:1), and the ages of the
patients have ranged from 18 to 84 with an average age of
54 years [1].
The most common presenting symptom is upper abdom-
inal fullness, with or without hepatomegaly. Abdominal
pain and discomfort, diarrhea, and weight loss can be
invariably encountered as well. Only about 7% of these
lesions manifest the carcinoid syndrome [1], the explana-
tion of which in part stems from hepatic enzymatic degra-
dation of neoplastic-derived products initially spilling
into the portal circulation rather than the systemic circu-
lation. Our patient exhibited no symptomatology other
than abdominal fullness and mild discomfort. Therefore
lab studies to detect carcinoid-related substances were not
performed.
The cell from which this entity arises has not been proven,
but there is evidence to support a derivation from bile
duct epithelium [3,4]. Ultrastructural findings include cell
clusters with lumina bordered by cells with microvilli and
junctional complexes, similar to the epithelial cells that
line bile ducts [3]. Roskams et al. showed that during the
earliest stages of regeneration, bile duct epithelium dis-
plays neuroendocrine features including cytoplasmic,
dense core neurosecretory granules and chromogranin-A
expression [4].
(A) Multiple areas of intravascular invasion are found throughout the liver (H&E, 400×)Figure 3
(A) Multiple areas of intravascular invasion are found 
throughout the liver (H&E, 400×). (B) A stain for the neu-
roendocrine marker chromogranin reveals the tumor border 
at the left edge of the photomicrograph (H&E, 100×) with 
multiple scattered neoplastic cells spilling into the surround-
ing liver parenchyma (inset, H&E, 400×).
(A) The enormous tumor has all but replaced and distorted the right hepatic lobect my specimenFigure 2
(A) The enormous tumor has all but replaced and distorted 
the right hepatic lobectomy specimen. (B) Cut sections 
reveal diffuse areas of necrosis and a large, irregular central 
scar. (C) The tumor is composed mostly of a trabecular 
architecture but with some scattered acinar structures (H&E, 
400×). The cells show mild atypia while displaying eccentric, 
"salt and pepper" nuclei and gritty pink cytoplasm (inset, 
H&E, 1000×).Page 3 of 5
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ing from 1 cm up to 20 cm in greatest dimension [3], but
approximately two-thirds of these tumors are found after
they have grown over 5 cm [1]. They are well-demarcated
from the surrounding liver parenchyma, and their cut sur-
faces are generally gray-yellow in color with multiple
irregular hemorrhagic areas. Necrosis is rare, and promi-
nent central scarring has not been described elsewhere as
far as we are aware.
The histologic architecture of hepatic carcinoid can vary
among solid, nested, trabecular, and microacinar arrange-
ments [3], as the latter two patterns predominated in this
case. The cells themselves are usually small and uniform
with round, centrally placed nuclei and granular chroma-
tin. Nucleoli are inconspicuous. Intratumoral hemor-
rhage can be abundant while the mitotic rate is usually
low, both of which characterized our lesion. Necrosis is
usually not present; and when it is identified, it is more
often focal or punctuate, in stark contrast to the extensive
necrotic areas we observed in this case.
Most primary hepatic carcinoids display typical histologic
features. Soga, however, reported a group of 19 carcinoids
designated as "atypical." We regret that the specific criteria
used to designate such cases as atypical are not discussed.
The lesion in this case showed few mitoses but revealed
mild atypia and exuberant necrosis. Its massive size, sinu-
soidal infiltration, and intravascular metastases further-
more suggest that this tumor should be described as an
atypical variant.
The immunohistochemical characteristics of hepatic carci-
noid include stain positivity for the neurosecretory mark-
ers chromogranin, synaptophysin, and neuron-specific
enolase. Cytokeratin tends to impart a granular perinu-
clear staining pattern. Markers for gastrin, serotonin, car-
cinoembryonic antigen, and pancreatic polypeptide are
inconsistently positive [1]. Stains for hepatocellular carci-
noma (HCC), including Hep-Par1 and AFP, are negative.
The neoplasm in this case mimics several more common
hepatic malignancies that may need to be considered in
subsequent cases. Grossly, the large irregular central scar
brought to mind the possibility of a fibrolamellar variant
of heptocellular carcinoma. Then, histologically, the pre-
dominantly trabecular architecture coupled with slight
nuclear atypia and extensive necrosis was very concerning
for HCC. Once the immunohistochemical stains were
examined, HCC could be safely ruled out. The neuroen-
docrine marker positivity prompted us briefly to consider
a neuroendocrine carcinoma, but these tumors are typi-
cally poorly differentiated and display prominent pleo-
morphism, nuclear atypia, and a high mitotic index.
Because of the presence of scattered acinar-like structures,
a mucicarmine stain was performed, the negative result of
which ruled out cholangiocarcinoma.
Currently, there do not appear to be any genetic studies
conducted on primary hepatic carcinoids, likely a result of
this neoplasm's rare occurrence. Multiple studies, how-
ever, have discovered cytogenetic and molecular aberra-
tions in gastrointestinal carcinoids from other locations
such as the ileum and pancreas [5-8]. As a future
endeavor, it may be worthwhile to investigate the possible
genetic changes in carcinoids primary to the liver and to
compare these changes to those found in other carcinoids.
A complete and thorough autopsy is the only way to prove
definitively that a carcinoid is truly primary to the liver, as
rectal and ileal carcinoids as small as 1 mm or less have
been known to produce large hepatic metastases and com-
prise the majority of carcinoids identified in the liver [2].
Of course, at this point, an autopsy would be of academic
interest only and not for the patient's benefit. In order to
safely rule out a non-hepatic primary source, Fenwick et
al. provide a diagnostic flow diagram that uses a combina-
tion of radiologic imaging studies, somatostatin scan,
endoscopy, laparotomy, and regular follow-up appoint-
ments [9]. In our case, the multiple radiologic studies that
were performed, including a somatostatin scan, coupled
with a thorough exploration of the bowel during the sur-
gical resection of the mass led to a strong, although not
definitive, clinical diagnosis of primary hepatic carcinoid.
The mainstay of treatment is surgical resection, although
some reports have shown the added benefits of systemic
chemotherapy and hepatic artery chemoembolus injec-
tion [10]. When given as the only form of therapy, chem-
otherapy drugs such as 5-FU and streptozocin provide a
favorable response in only one-third of patients [10].
The overall five-year survival rate for primary hepatic car-
cinoids is excellent, averaging 92%, while the metastasis
rate is 45% [1]. Survival times have ranged from several
months up to eighteen years [10]. Of the seven cases of
atypical carcinoid followed post-operatively in an article
by Soga, all patients were alive well past thirty months [1].
These numbers are small but so far do not indicate a sig-
nificant difference in survival times between typical and
atypical hepatic carcinoids.
At the time of this writing, our patient has reached the
eight-month post-operative milestone and is both symp-
tom-free and disease-free. Of course, it will be of great
interest as we continue to follow her for survivorship com-
parisons and tumor behavior. Will these atypical patho-
logic features predict a worse outcome? Only time may
tell.Page 4 of 5
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Here we have presented the case of giant primary hepatic
carcinoid tumor with a number of atypical features
including an enormous size, mild cytologic atypia, abun-
dant necrosis, and intravascular metastases. We also
describe the lesion's unusual sinusoidal infiltration of the
surrounding liver parenchyma, a feature that has not been
described as far as we are aware but could potentially serve
as a future prognostic finding. As more cases arise, it may
be possible to establish a set of guidelines to define atypia
in hepatic carcinoids and other gastrointestinal carci-
noids, similar to what has been done for their pulmonary
counterparts. Thus far, however, based on the current sur-
vivorship data, a typical versus atypical diagnosis for these
neoplasms may not be necessary other than for academic
purposes. Finally, albeit rare, this entity should not be
confused with other, more common hepatic lesions such
as hepatocellular carcinoma, which carries a significantly
worse prognosis and possibly a different treatment regi-
men.
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